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Key Clinical Message
Studies have shown that difference in mtDNA mutation load among tissues is a
result of postnatal modification. We present five family members with the
m.8344A>G with variable phenotypes but uniform intrapersonal distribution of
mutation load, indicating that there is no postnatal modification of mtDNA
mutation load in this genotype.
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Introduction
Clinical presentation of patients with mitochondrial DNA
(mtDNA) mutation differs tremendously. Thus, even
patients harboring the same genotype can present with
symptoms ranging from monosymptomatic muscle weak-
ness to multiorgan involvement. The clinical variety is, at
least in part, a result of differences in mtDNA mutation
load among tissues. Findings of high mtDNA mutation
load in postmitotic tissues and low levels in highly mito-
tic tissues [1, 2] has prompted the idea, that there is post-
natal modification of mtDNA mutation load depending
on the mitotic status of the tissue.
The m.8344A>G point mutation is generally associated
with the clinical phenotype myoclonus epilepsy and
ragged-red fibers (MERRF) [3]. However, clinical presen-
tation in this patient group varies [4] and symptoms such
as hearing impairment, migraine, and psychiatric disor-
ders may be just as common [5], and clinical case reports
have even associated the m.8344A>G genotype with a
phenotype of multiple lipomas [6–15]. We report the
clinical, physiological, morphological, and biochemical
findings along with mtDNA mutation load in both mito-
tic and postmitotic tissues in five family members with
the m.8344A>G point mutation lipomas in two. We
found a uniform intrapersonal distribution of mutation
level and the mtDNA mutation load did not correlate
with age. These findings indicate, that there is no postna-
tal modification of mutation in patients with the
m.8344A>G as it is seen in patients with other common
point mutation of mtDNA [1, 2].
Case Presentation
Subjects
The study included five maternally related family mem-
bers: Three sisters, their mother, and their uncle
(Table 1). The proband (the eldest sister) was originally
admitted to our neuromuscular clinic for diagnostic pur-
pose due to symptoms of reduced mental abilities and
premature fatigue. Additionally, during the last 2 years
prior to admission, she had begun developing lipomas in
the upper back and submandibular regions (Fig. 1A). The
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second oldest sister also suffered from reduced mental
abilities and had a masculine appearance (broad shoul-
ders, large hands and feet, and hair growth on her upper
lip; see Fig. 1B) indicating an endocrine dysfunction. The
youngest sister was asymptomatic, and diagnosis was car-
ried out due to concerns from her and her mother. Their
mother was asymptomatic, while their maternal uncle
complained of premature fatigue and had numerous,
large lipomas in the submandibular and upper back
regions. For cosmetic reasons, these lipomas had been
partially removed by surgical excision (Fig. 1C) before
admitted to our neuromuscular clinic.
The patients were seen in our neuromuscular clinic for
diagnostic purpose, and for this reason, the study did not
need an approval from an ethical committee.
Investigations
Clinical examination
All patients had a neurological examination including
muscle strength assessment by Medical Research Council
(MRC) scale.
Genetic investigations
In all five subjects, the load of the m.8344A>G point
mutation was investigated in skeletal muscle, blood, and
urine- and buccal epithelial cells. In the proband and
the uncle, mtDNA mutation load was assessed in
apparently unaffected fat tissue and from lipomas. The
biopsy, from apparent unaffected fat tissue, was taken
from abdominal adipose tissue, and the biopsy of
lipoma was taken from the submandibular region/chin.
MtDNA mutation load was assessed via methods previ-
ously described [16, 17].
Biochemical investigations
Plasma creatine kinase (CK) levels and mitochondrial
enzyme complex I-IV and citrate synthase (CS) activities
in muscle were measured in all patients according to
methods previously described [18].
Morphological investigations
Serially cut muscle sections were evaluated for number of
internally nucleated fibers, ragged-red fibers, COX nega-
tive fibers, and fibers with fat infiltration with standard
staining methods.
Functional testing
Maximal oxidative capacity (VO2max) and plasma lactate
levels at rest and peak exercise were measured in all
patients according to methods previously described [19].
The findings were compared to that found in 20 healthy
sedentary control subjects (10 men and 10 women) pre-
sented in Jeppesen et al., 2006 [1].
Table 1. Demographic, morphologic, and biochemical findings in each family member.
Proband Sister I Sister II Mother Uncle
Age (years) 27 17 14 46 52
Height (cm) 165 171 171 175 173
Weight (kg) 74 100 53 65 86
RRF (%) 10 0 0 <1 0
Cox fibers (%) 90 0 0 <1 <1
CNF (%) 4 <1 0 0 <1
ICF (%) Heavy Minor None Minor Minor
Resting lactate (mmol/L) 7.1* (2.3) 3.4* (2.3) 1.9 (2.3) 3.1* (2.3) 2.1 (2.3)
Peak lactate (mmol/L) 15.5* (11.8) 9.6 (11.8) 5.2 (11.8) 12.8* (11.8) 8.5 (11.8)
P-CK (mmol/L) 344 123 58 231 5
CS (mU/mg protein) 301 89 119 87 96
CI/CS 0.05† 0.47 0.36 0.23 0.10†
CII/CS 0.36 0.43 0.41 0.31 0.31
CIII/CS 0.29† 1.54 1.82 1.03 0.78
CIV/CS 0.5† 4.5 4.7 2.3 1.3†
Sister I = the second oldest sister, Sister II = the youngest sister, RRF = ragged-red fibers, CNF = centrally nucleated fibers, ICF = intracellular fat
accumulation, P-CK = plasma creatine kinase, CS = citrate synthase, CI-CIV = mitochondrial enzyme complexes I-IV. Activities of the mitochondrial
enzyme complexes are corrected for CS activity, and are thus expressed as ratios. Normal ranges for these ratios are expressed as mean  two
standard deviations (2SDs). *Higher than the upper limit of plasma lactate measured in 20 healthy subjects. †Activity lower than 2SDs from the
mean. The numbers in parenthesis in row 10 and 11 denotes the upper reference level for resting plasma lactate (row 10) and peak exercise lac-
tate level (row 11).
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Results
Clinical examination revealed generalized reduced muscle
strength in the proband (4), the second oldest sister (4+)
and the uncle (4+).
Genetic investigation revealed the m.8344A>G point
mutation in all family members. The mtDNA mutation
load level was 60–99% in the investigated tissues
(Fig. 2A). The intrapersonal levels in mtDNA mutation
load were rather uniform in blood, skeletal muscle, urine
epithelial cells, and buccal mucosa. In the uncle, there
was a large difference between apparent healthy adipose
tissue (63%) versus lipoma (87%), while the difference
between apparent normal adipose cells and lipomas was
less pronounced in the proband (87% vs. 95%).
Activities of mitochondrial enzyme complexes I and IV
were reduced in the proband and the uncle, and in addi-
tion complex III was impaired in the proband (Table 1).
VO2max was 73% lower in the proband and 54% lower in
the uncle compared to age- and gender-matched healthy
subjects (Fig. 2B). However, the uncle stopped exercising
prematurely due to pain in the right knee. Thus, the
VO2max may be “false” low, since the uncle did not reach
exercitation. VO2max may therefore be underestimated in
the uncle. The VO2max of the remaining family members
was low within the normal range (Fig. 2B). Only the pro-
band had elevated plasma CK level, while resting plasma
lactate levels were elevated in the proband, the second old-
est sister, and the mother. At peak exercise, lactate was ele-
vated in the proband and the mother (Table 1).
(A)
(B)
(C)
Figure 1. Photographs of the patients with the 8344A>G point mutation of mtDNA. The pictures show the proband aged 27 (A), her younger
sister (age 17) (B), and her maternal uncle (age 52) (C). Black arrows indicate the presence of lipomas in A and C, and also the presence of scars
in C.
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Morphological investigations revealed abnormal muscle
morphology in the proband while muscle morphology
was normal in the rest of the family members (Table 1).
Conclusions
In this study, we report the pattern of mtDNA mutation
load in mitotic- and postmitotic tissues in five maternally
related family members harboring the m.8344A>G point
mutation with presentation of multiple lipomas in two of
the family members. We found a uniform distribution of
mtDNA mutation load among tissues, except for lipomas
in one family member, where mtDNA mutation load was
much higher in lipomas cells compared to apparent nor-
mal adipose tissue.
Previous case studies that have described patients with
lipomas carrying the m.8344A>G point mutation have
found that lipomas seem to develop over time [6–15],
and patients have presented with lipomas at middle age
like the uncle in this study. In contrast, the proband pre-
sented with lipomas in her twenties. We have previously
shown, that when tested in the same tissue, there is a
close relationship between mtDNA mutation load and tis-
sue phenotype, which indicates that symptoms emerge
when mtDNA mutation load reaches a certain level in the
tissue [1, 19]. At which mtDNA mutation level lipomas
develop from adipose cells are unknown, but the mtDNA
mutation threshold was apparently exceeded in the adi-
pose tissue situated submandibular in the uncle and the
proband. We have no explanation for the differences in
mtDNA mutation load in apparent healthy adipose tissue
at abdomen versus submandibular lipomas especially in
the uncle, where the difference was large. Factors, besides
mtDNA mutation load, determining whether lipomas
develop or not, could be site-specific genetic background
that has been found in adipose tissue [20]. This mecha-
nism is pure speculation and needs to be addressed in
future studies. In the proband, the difference between
mtDNA mutation load in apparent normal adipose tissue
versus lipomas was much smaller than that seen in the
uncle, which may relate to a ceiling off effect due to the
high mtDNA mutation load levels.
We have previously shown, that the mtDNA mutation
level at which oxidative impairment emerge in skeletal
muscle tissue is 55–65% in patients with the common
m.3243A>G point mutation of mtDNA [1, 19] and 40–
50% in patients with large-scale deletion of mtDNA [19].
In this study, the proband had the highest mtDNA muta-
tion load in skeletal muscle compared to the four other
family members. In line with the high mtDNA mutation
load, the proband was more affected in skeletal muscle
(pathologic findings on muscle biopsy, increased CK level,
increased plasma lactate, impaired mitochondrial respira-
tory complex activity, and reduced VO2max) versus the
rest of the family members. Due to the high level of
mtDNA mutation load in all tissues investigated (>60%)
and due to the low number of patients (n = 5), it is not
possible to establish a mtDNA threshold, at which
patients with the m.8344A>G mutation develop symp-
toms of skeletal muscle tissue. The second eldest sister
and the mother had normal VO2max, CK, muscle mor-
phology, and mitochondrial respiratory complex activity
despite high mtDNA mutation load in skeletal muscle
(80% and 85%). These data indicate that the threshold
level for mtDNA mutation load, at which oxidative
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Figure 2. Load of the m.8344A>G mutation among different tissues
in each of the five family members (A) and maximal oxidative capacity
(VO2max) of each family member as determined by cycle ergometry
testing (B). (A) Each bar represents a tissue as explained by the legend
box. The tissues investigated are the vastus lateralis muscle (muscle),
urine epithelial cells (urine), buccal epithelial cells (mouth), leukocytes
(blood), clinically unaffected adipose tissue from the abdominal region
(adipose), and lipoma tissue from the upper back region (lipoma).
Samples from the latter two tissues were only collected from the
proband and the uncle as they were the only family members with
lipomas. Sister I = the second oldest sister, Sister II = the youngest
sister. (B) Corresponding values from healthy, age-matched, male (in
blue) and female (in red) subjects are plotted for comparison. The
solid lines indicate the mean value. Broken lines indicate two standard
deviations above and below the mean. Sister I = the second oldest
sister, Sister II = the youngest sister.
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capacity becomes impaired, is higher in patients with the
m.8344A>G mutation than in patients with the
m.3243A>G mutation.
Studies have showed that mtDNA mutation load level
in mitotic tissue decrease over time in patients with the
m.3243A>G point mutation [2] and single large-scale
deletion of mtDNA [21] and accumulate over time in
postmitotic tissue in patients with single large-scale dele-
tions [22]. These findings have prompted the idea, that
there is a postnatal modification of mutation load in
patients with mtDNA mutations, which is determined by
the mitotic dynamics of the tissue. In this study, the
intrapersonal mtDNA mutation load was quite similar
among the tested tissues, which indicates that the pattern
of segregation is different in the m.8344A>G mutation.
In conclusion, this study demonstrates a highly variable
intrafamilial phenotype in persons carrying the
m.8344A>G mutation, despite an overall uniform intrap-
ersonal distribution of the mutation load in various tis-
sues, except in adipose tissue in one patient. The
difference between mtDNA mutation load between
abdominal and submandibular adipose cells may relate to
site-specific differences in genetic background and
mtDNA mutation load.
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